Cargando…
Plasma Transthyretin as a Predictor of Amnestic Mild Cognitive Impairment Conversion to Dementia
Amnestic mild cognitive impairment (MCI) is a prodromal stage of dementia, with a higher incidence of these patients progressing to Alzheimer’s disease (AD) than normal aging people. A biomarker for the early detection and prediction for this progression is important. We recruited MCI subjects in th...
Autores principales: | Tien, Yi-Ting, Lee, Wei-Ju, Liao, Yi-Chu, Wang, Wen-Fu, Jhang, Kai-Ming, Wang, Shuu-Jiun, Fuh, Jong-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904474/ https://www.ncbi.nlm.nih.gov/pubmed/31822765 http://dx.doi.org/10.1038/s41598-019-55318-0 |
Ejemplares similares
-
Plasma MCP-1 and Cognitive Decline in Patients with Alzheimer’s Disease and Mild Cognitive Impairment: A Two-year Follow-up Study
por: Lee, Wei-Ju, et al.
Publicado: (2018) -
Frontal-executive dysfunction affects dementia conversion in patients with amnestic mild cognitive impairment
por: Jung, Young Hee, et al.
Publicado: (2020) -
Prediction of conversion to dementia using interpretable machine learning in patients with amnestic mild cognitive impairment
por: Chun, Min Young, et al.
Publicado: (2022) -
Contribution of Memory Tests to Early Identification of Conversion from Amnestic Mild Cognitive Impairment to Dementia
por: Vyhnalek, Martin, et al.
Publicado: (2022) -
Prognostic relevance of gait-related cognitive functions for dementia conversion in amnestic mild cognitive impairment
por: Tuena, Cosimo, et al.
Publicado: (2023)